Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$307,617,113
+$75,940,718 QoQ
Shares Held
11,960,230
-0.9% QoQ
Ownership
7.48%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3
of 293 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $3,256,235,173 across 13 Biotechnology names. DNLI ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
18,206,778 | $1,275,020,662 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,439,889 | $734,479,783 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,015,578 | $561,573,456 | |
| 4 | DNLI |
Denali Therapeutics Inc.
This page
|
11,960,230 | $307,617,113 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,561 | $135,389,224 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
23,487,907 | $86,200,617 | |
| 7 | BNTX |
BioNTech SE
|
592,380 | $55,120,957 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
263,466 | $49,341,910 |
All Filings in DNLI
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,617,115 | 11,960,230 | Shares | Sole | 2026-08-04 | |
| 2026-06-30 | $307,617,113 | 11,960,230 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $231,676,395 | 12,066,479 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $203,252,775 | 12,310,889 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $168,309,813 | 11,591,585 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $167,254,967 | 11,955,323 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $164,364,091 | 12,090,040 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $250,957,912 | 12,313,931 | Shares | Defined | 2025-01-31 | |
| 2024-12-31 | $55,843,278 | 2,740,102 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $388,765,686 | 13,345,887 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $319,590,698 | 13,763,596 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $288,125,996 | 14,041,228 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $306,035,135 | 14,260,724 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $302,869,586 | 14,681,027 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $438,039,650 | 14,843,770 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $353,712,636 | 15,352,111 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $420,472,570 | 15,119,474 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $451,604,912 | 14,715,051 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $437,605,675 | 14,869,374 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $481,920,496 | 14,980,432 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $671,514,591 | 15,056,381 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $757,245,215 | 15,009,816 | Shares | Defined | 2021-10-19 | |
| 2021-06-30 | $1,188,178,762 | 15,147,613 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $742,025,746 | 12,995,197 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $1,021,055,841 | 12,190,256 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $387,937,785 | 10,827,178 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $224,370,908 | 9,279,194 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $159,861,955 | 9,129,752 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||